Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference

WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced that management will participate in a fireside chat at 10:00 a.m. E.T. on Tuesday, November 12, 2024 at Guggenheim's Inaugural Healthcare Innovation Conference in Boston, MA.A webcast of the presentation will be available on the Events and Presentations page of Q32 Bio's website at www.q32bio.co ...